3/31
08:16 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Report
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
3/25
08:18 am
cgon
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Low
Report
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
3/7
12:26 pm
cgon
CG Oncology, Inc. (NASDAQ: CGON) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $55.00 price target on the stock.
Low
Report
CG Oncology, Inc. (NASDAQ: CGON) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $55.00 price target on the stock.
3/7
12:26 pm
cgon
CG Oncology, Inc. (NASDAQ: CGON) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $55.00 price target on the stock.
Low
Report
CG Oncology, Inc. (NASDAQ: CGON) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $55.00 price target on the stock.
3/7
12:14 pm
cgon
Rating for CGON
Low
Report
Rating for CGON
3/7
12:14 pm
cgon
Rating for CGON
Low
Report
Rating for CGON
1/10
01:13 pm
cgon
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Low
Report
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.